HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Cesar Rodriguez Valdez, MD

Associate Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai Center of Excellence for Multiple Myeloma, The Tisch Cancer Institute at Mount Sinai

Clinical Expertise

Multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS)

 

 

About

Dr. Cesar Rodriguez is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, and the Center of Excellence for Multiple Myeloma, and serves as Clinical Director of Multiple Myeloma at The Mount Sinai Hospital, Dr. Rodriguez has extensive experience treating patients with plasma cell disorders including multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS). He is a member of the International Myeloma Working Group which conducts collaborative research and produces consensus guidelines for the myeloma community.

Dr. Rodriguez has more than 10 years of experience in clinical research and is the principal investigator of numerous clinical trials for multiple myeloma focused on early drug development and immunotherapies that include T cell and NK cell directed therapies. He also is working on a 3D organoid model to better understand the biology of the tumor niche.

Dr. Rodnguez speaks English, Spanish, French, and Italian.

Location

Icahn School of Medicine at Mount Sinai: 1 Gustave L. Levy Pl, New York, NY 10029, USA

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube